AGA 研究所临床实践更新:美国的内镜黏膜下剥离术
本专家综述由 AGA 研究所发布,围绕 16 条最佳实践建议,更新内镜黏膜下剥离术(ESD)在美国的临床应用,涵盖胃、Barrett 食管、食管鳞癌、十二指肠、结直肠病变的适应证、操作要点、标本处理、培训及转诊教育。
要点
- ESD 是成熟的内镜技术,可整块切除过大或含癌风险高的病变。
- 早期胃癌绝对适应证为分化良好、无溃疡、≤2 cm 的黏膜病变。
- 美国内镜医师在 ESD 执业早期应避免行十二指肠 ESD。
核心结论
- ESD 是成熟的内镜技术,可完整切除过大或含癌风险高的病变;美国可培养高水平 ESD 能力,应采用阶梯式培训模式。
研究设计与样本
- AGA 研究所专家综述,基于作者共识的 16 条最佳实践建议,反映作者在美国实施和教授 ESD 的经验。
主要发现
- 早期胃癌 ESD 安全可行,绝对适应证为分化良好、无溃疡、≤2 cm 的黏膜病变。
- 胃癌扩展适应证包括分化良好 >2 cm 的浅表癌、≤3 cm 伴溃疡或早期黏膜下浸润的病变、≤2 cm 的低分化浅表癌,淋巴结转移风险高于绝对适应证但仍可接受。
- 大肠病变 >2 cm 时 EMR 分块切除率 >43%,相关复发率高达 20%;ESD 整块切除率更高、复发率更低。
关键数值与推荐
- 胃 ESD 绝对适应证:分化良好、无溃疡、≤2 cm 的黏膜病变。
- 胃 ESD 扩展适应证:分化良好 >2 cm 的浅表癌、≤3 cm 伴溃疡或早期黏膜下浸润、≤2 cm 的低分化浅表癌。
- Barrett 食管可考虑 ESD 的特征:大或 bulky 结节区、高概率浅表黏膜下浸润、复发性异型增生、EMR 标本示浸润癌切缘阳性、术前组织学不确定、黏膜内癌。
- 食管鳞状异型增生和局限于浅表黏膜的癌以 ESD 为主要治疗方式;任何程度的黏膜下浸润均增加淋巴结转移风险,应考虑替代或额外治疗。
- 大肠病变 >2 cm 时 EMR 分块切除率 >43%,复发率高达 20%;黏膜内异型增生无淋巴结转移风险,内镜切除应视为金标准。
临床怎么用
- 美国内镜医师在 ESD 执业早期强烈建议避免行十二指肠 ESD;十二指肠 ESD 应限于在其他部位有丰富 ESD 经验的内镜医师。
- 美国内镜医师开始 ESD 前应熟悉可用内镜组织闭合装置; clip 闭合和内镜缝合对术中穿孔有效;特定情况下可考虑完全闭合 ESD 术后创面。
- 推荐使用低电压凝固电流对切除部位暴露血管行仔细凝血,可能降低 ESD 术后迟发出血风险。
- ESD 标本应固定在平面(如钉在软木板上)并浸入福尔马林,由胃肠道病理专家评估切缘、分化程度、淋巴血管侵犯、黏膜下浸润深度和肿瘤出芽。
- 美国 ESD 培训最适模式为阶梯式:自学理论、参加难度递增的培训课程、动物模型自我练习、观摩专家现场操作;初始 ESD 应选择适应证明确、技术难度最低的病变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endoscopic submucosal dissection (ESD) is an established endoscopic resection method in Asian countries, which is increasingly practiced in Europe and by early adopters in the United States for removal of early cancers and large lesions from the luminal gastrointestinal tract. The intent of this expert review is to provide an update regarding the clinical practice of ESD with a particular focus on its use in the United States. This review is framed around the 16 best practice advice points agreed upon by the authors, which reflect landmark and recent published articles in this field. This expert review also reflects our experience as advanced endoscopists with extensive experience in performing and teaching others to perform ESD in the United States. Best Practice Advice 1: Endoscopic submucosal dissection should be recognized as a mature endoscopic technique that enables complete removal of lesions that are too large for en bloc endoscopic mucosal resection or are at increased risk of containing cancer. Best Practice Advice 2: The safety and feasibility of endoscopic submucosal dissection for early gastric cancer is well established. The absolute indications for curative endoscopic resection include moderately and well-differentiated, nonulcerated, mucosal lesions that are ≤2 cm in size. Best Practice Advice 3: Other relative (expanded) indications for gastric endoscopic submucosal dissection include moderately and well-differentiated superficial cancers that are >2 cm, lesions ≤3 cm with ulceration or that contain early submucosal invasion, and poorly differentiated superficial cancers ≤2 cm in size. The risk of lymph node metastasis when endoscopic submucosal dissection is performed for these indications is higher than when it is performed for absolute indications but remains acceptably low. Best Practice Advice 4: Endoscopic submucosal dissection may be considered in selected patients with Barrett's esophagus with the following features: large or bulky area of nodularity, lesions with a high likelihood of superficial submucosal invasion, recurrent dysplasia, endoscopic mucosal resection specimen showing invasive carcinoma with positive margins, equivocal preprocedural histology, and intramucosal carcinoma. Best Practice Advice 5: Endoscopic submucosal dissection is the primary modality for treatment of squamous cell dysplasia and cancer confined to the superficial esophageal mucosa. Any degree of submucosal invasion caries an increased risk of lymph node metastasis and alternative/additional therapy should be considered. Best Practice Advice 6: Duodenal endoscopic submucosal dissection is associated with an increased risk of intraprocedural perforation and delayed adverse events. Duodenal endoscopic submucosal dissection should be limited to endoscopists with extensive experience in performing endoscopic submucosal dissection in other locations. It is strongly suggested that endoscopists in the United States refrain from performing duodenal endoscopic submucosal dissection during the early phase of their endoscopic submucosal dissection practice. Best Practice Advice 7: All colorectal lesions should be evaluated for suitability for endoscopic resection. Accumulating evidence has shown that the majority of colorectal neoplasms without signs of deep submucosal invasion or advanced cancer can be treated by advanced endoscopic resection techniques. Best Practice Advice 8: Colorectal neoplasms containing dysplasia confined to the mucosa have no risk for lymph node metastasis and endoscopic resection should be considered as the criterion standard. Best Practice Advice 9: Large (>2 cm) colorectal lesions frequently (>43%) require piecemeal removal when endoscopic mucosal resection is used, which is associated with increased (up to 20%) rates of recurrent neoplasia. Endoscopic submucosal dissection enables higher rates of en bloc resection and lower recurrence rates for these lesions. Patients with large complex colorectal polyps should be referred to a high-volume, specialized center for endoscopic removal by endoscopic mucosal resection or endoscopic submucosal dissection. Best Practice Advice 10: Endoscopic resection for colorectal lesions offers significant cost benefit compared with surgery, and case-based endoscopic submucosal dissection selection for high-risk lesions could offer cost savings. Best Practice Advice 11: Endoscopists in the United States embarking on performing endoscopic submucosal dissection should be familiar with currently available endoscopic tissue closure devices. Both clip closure and endoscopic suturing techniques have been shown to be effective in managing intraprocedural perforation. Complete closure of a post-endoscopic submucosal dissection site may be considered in certain circumstances based on patient factors, procedural factors, and the location of the lesion. Best Practice Advice 12: Careful coagulation of exposed blood vessels in the resection site may reduce the risk of delayed bleeding after endoscopic submucosal dissection. The use of low-voltage coagulation current is recommended for this technique. Best Practice Advice 13: Endoscopists should affix the endoscopic submucosal dissection specimen to a flat surface (eg, pin the specimen to cork board) and immerse it in formalin. An expert gastrointestinal pathologist should evaluate the specimen for margin involvement, degree of differentiation, presence or absence of lymphovascular invasion, depth of submucosal invasion (if present), and tumor budding. Best Practice Advice 14: Acquiring high-level competency in endoscopic submucosal dissection is achievable in the United States. Alternative educational models should be used in the United States because of the limited number of experts and the differing prevalence of gastrointestinal luminal diseases as compared with Asia. Best Practice Advice 15: The endoscopic submucosal dissection educational model most suited for the current environment in the United States is a stepwise approach consisting of didactic self-study, attending training courses with increasing levels of complexity, self-practice on animal models, and observation of live cases performed by experts. Endoscopists should perform their initial endoscopic submucosal dissections on patients with lesions that have well-established indications for endoscopic submucosal dissection and are of the lowest technical complexity. Best Practice Advice 16: Endoscopists in the United States who perform endoluminal resection should educate referring physicians to avoid practices that may induce submucosal fibrosis hampering future endoscopic mucosal resection or endoscopic submucosal dissection. These practices include tattooing in close proximity to or beneath a lesion for marking and partial snare resection of a portion of a lesion for histopathology.
引用
- Draganov PV, Wang AY, Othman MO, et al. AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States. Clin Gastroenterol Hepatol. 2018. PMID: 30077787. doi:10.1016/j.cgh.2018.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。